Statistiques
- Consultations du résumé : 384
- Article intégral : 171
depuis 29/04/2011
Services
-
Articles des mêmes auteurs
- PubMed - Recommander cet article
- Exporter cette référence
BibSonomy
CiteUlike
Del.icio.us
Digg
Facebook
Mendeley
TwitterAccès gratuit
|
|||||||||||||||||||||
- KawaiT, MalechHL. WHIM syndrome : congenital immune deficiency disease. Curr Opin Hematol 2009 ; 16 : 20-26. [CrossRef] [PubMed]
- HernandezPA, GorlinRJ, LukensJN, et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 2003 ; 34 : 70-74. [CrossRef] [PubMed]
- DoorbarJ. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 2006 ; 110 : 525-541. [CrossRef] [PubMed]
- BalabanianK, LaganeB, PablosJL, et al. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. Blood 2005 ; 105 : 2449-2457. [CrossRef] [PubMed]
- CiprianiNA, BlairE, TaxyJB. WHIM syndrome and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010 ; 109 : 105-108. [CrossRef] [PubMed]
- TassoneL, MorattoD, VermiW, et al. Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients. Blood 2010 ; 116 : 4870-4873. [CrossRef] [PubMed]
- HandisuryaA, SchellenbacherC, ReiningerB, et al. A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome. Vaccine 2010 ; 28 : 4837-4841. [CrossRef] [PubMed]
- FlorinL, Maas-SzabowskiN, WernerS, et al. Increased keratinocyte proliferation by JUN-dependent expression of PTN and SDF-1 in fibroblasts. J Cell Sci 2005 ; 118 : 1981-1989. [CrossRef] [PubMed]
- ChowKY, BrotinÉ, Ben KhalifaY, et al. A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes : clues to understanding HPVpathogenesis in WHIM syndrome. Cell Host Microbe 2010 ; 8 : 523-533. [CrossRef] [PubMed]
- ChapmanS, LiuX, MeyersC, et al. Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J Clin Invest 2010 ; 120 : 2619-2626. [CrossRef] [PubMed]
- BignonA, BiajouxV, Bouchet-DelbosL, et al. CXCR4, une cible thérapeutique dans certains déficits immunitaires rares ?Med Sci (Paris) 2011 ; 27 : 391-397. [CrossRef] [EDP Sciences] [PubMed]